Jump to content

Tom Perls: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Added short description.
Tags: Mobile edit Mobile web edit Advanced mobile edit
m Added a link.
Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
Line 1: Line 1:
{{short description|Founding director of the New England Centenarian Study}}
{{short description|Founding director of the New England Centenarian Study}}
'''Thomas Perls''' (born 1960) is the founding director of the [[New England Centenarian Study]], the longest running largest study of centenarians and their family members in the world.<ref name="bugreen">{{cite web|url=http://www.bumc.bu.edu/centenarian|title=The new England Centenarian Study|year=2002|publisher=Boston University|accessdate=1 July 2013}}</ref> The Study is worldwide in scope but most of the participants come from the United States and Canada and is funded by three National Institute on Aging grants: The Integrative Longevity Omics Study, Centenarian Project of the Longevity Consortium and the Long Life Family Study. The study is also funded, with great appreciation, by the William M. Wood Foundation and the Paulette and Marty Samowitz Foundation. Born in [[Palo Alto]], [[California]], Perls later moved to [[Colorado]] and now lives in Boston. He received his B.A. from [[Pitzer College]] in 1982, his M.D. from the [[University of Rochester Medical Center|University of Rochester School of Medicine and Dentistry]] in 1986 and his M.P.H. from [[Harvard University]] in 1993.<ref name="cnn03">{{cite news|url=http://www.cnn.com/2001/CAREER/jobenvy/08/27/thomas.perls.focus/index.html|title=Thomas Perls: Longevity researcher |last=Anderson |first=Porter |publisher=Cable News Network |accessdate=15 June 2015 | date=27 August 2001}}</ref> Perls is Professor of medicine at [[Boston University School of Medicine]] and [[attending physician]] in geriatrics at [[Boston Medical Center]]. He is author of over 160 peer reviewed articles primarily in the areas of biodemography and genetics of human exceptional longevity and anti-aging quackery.
'''Thomas Perls''' (born 1960) is the founding director of the [[New England Centenarian Study]], the longest running largest study of [[Centenarian|centenarians]] and their family members in the world.<ref name="bugreen">{{cite web|url=http://www.bumc.bu.edu/centenarian|title=The new England Centenarian Study|year=2002|publisher=Boston University|accessdate=1 July 2013}}</ref> The Study is worldwide in scope but most of the participants come from the United States and Canada and is funded by three National Institute on Aging grants: The Integrative Longevity Omics Study, Centenarian Project of the Longevity Consortium and the Long Life Family Study. The study is also funded, with great appreciation, by the William M. Wood Foundation and the Paulette and Marty Samowitz Foundation. Born in [[Palo Alto]], [[California]], Perls later moved to [[Colorado]] and now lives in Boston. He received his B.A. from [[Pitzer College]] in 1982, his M.D. from the [[University of Rochester Medical Center|University of Rochester School of Medicine and Dentistry]] in 1986 and his M.P.H. from [[Harvard University]] in 1993.<ref name="cnn03">{{cite news|url=http://www.cnn.com/2001/CAREER/jobenvy/08/27/thomas.perls.focus/index.html|title=Thomas Perls: Longevity researcher |last=Anderson |first=Porter |publisher=Cable News Network |accessdate=15 June 2015 | date=27 August 2001}}</ref> Perls is Professor of medicine at [[Boston University School of Medicine]] and [[attending physician]] in geriatrics at [[Boston Medical Center]]. He is author of over 160 peer reviewed articles primarily in the areas of biodemography and genetics of human exceptional longevity and anti-aging quackery.


Generally, the study has found that centenarians and their children (in their 70s thru 90s) age relatively slowly and have decreased risk for aging-related diseases including Alzheimer's, cancer, diabetes, cardiovascular disease, stroke and restrictive lung disease. Our studies are using different but synergistic approaches to discover the biological and environmental exposure and behavioral mechanisms by which these individuals age so well and live so long.
Generally, the study has found that centenarians and their children (in their 70s thru 90s) age relatively slowly and have decreased risk for aging-related diseases including Alzheimer's, cancer, diabetes, cardiovascular disease, stroke and restrictive lung disease. Our studies are using different but synergistic approaches to discover the biological and environmental exposure and behavioral mechanisms by which these individuals age so well and live so long.

Revision as of 15:00, 24 April 2021

Thomas Perls (born 1960) is the founding director of the New England Centenarian Study, the longest running largest study of centenarians and their family members in the world.[1] The Study is worldwide in scope but most of the participants come from the United States and Canada and is funded by three National Institute on Aging grants: The Integrative Longevity Omics Study, Centenarian Project of the Longevity Consortium and the Long Life Family Study. The study is also funded, with great appreciation, by the William M. Wood Foundation and the Paulette and Marty Samowitz Foundation. Born in Palo Alto, California, Perls later moved to Colorado and now lives in Boston. He received his B.A. from Pitzer College in 1982, his M.D. from the University of Rochester School of Medicine and Dentistry in 1986 and his M.P.H. from Harvard University in 1993.[2] Perls is Professor of medicine at Boston University School of Medicine and attending physician in geriatrics at Boston Medical Center. He is author of over 160 peer reviewed articles primarily in the areas of biodemography and genetics of human exceptional longevity and anti-aging quackery.

Generally, the study has found that centenarians and their children (in their 70s thru 90s) age relatively slowly and have decreased risk for aging-related diseases including Alzheimer's, cancer, diabetes, cardiovascular disease, stroke and restrictive lung disease. Our studies are using different but synergistic approaches to discover the biological and environmental exposure and behavioral mechanisms by which these individuals age so well and live so long.

Perls is the author of the online "Living to 100 Life Expectancy Calculator".[3] Perls is a prominent critic of "hormone replacement therapy" including growth hormone and testosterone for "anti-aging" and "age-management".[4] He is author of the website hghwatch.com.[5] and he has testified before the U.S. Congress,[6] as well as provided written testimony for the U.S. Sentencing Commission regarding illegal distribution of growth hormone for anti-aging.[7] Perls is the author of several academic articles about the medical misuse and illegal distribution of growth hormone and anabolic steroids, including testosterone, for anti-aging and bodybuilding.[8][9][10]

References

  1. ^ "The new England Centenarian Study". Boston University. 2002. Retrieved 1 July 2013.
  2. ^ Anderson, Porter (27 August 2001). "Thomas Perls: Longevity researcher". Cable News Network. Retrieved 15 June 2015.
  3. ^ Perls, Thomas. "Living to 100 Life Expectancy Calculator". Thomas Perls. Retrieved 30 December 2013.
  4. ^ "Anti-Aging Quackery: Human Growth Hormone and Tricks of the Trade—More Dangerous Than Ever". Oxford Press. 2004. Retrieved 18 November 2013.
  5. ^ Perls, Tom (2006). "hghwatch". Retrieved 1 July 2013.
  6. ^ "Committee holds hearing on myths and facts about human growth hormone, B12, and other substances". U.S. House of Representatives. 2008. Retrieved 8 November 2013.
  7. ^ "Sentencing of human growth hormone offenses". Thomas Perls. 2008. Retrieved 1 July 2013.
  8. ^ "Provision or Distribution of Growth Hormone for "Antiaging". Clinical and Legal Issues". JAMA. 2005. Retrieved 18 November 2013.
  9. ^ "New Developments in the Illegal Provision of Growth Hormone for "Anti-Aging" and Bodybuilding". JAMA. 2008. Retrieved 18 November 2013.
  10. ^ Perls, Thomas T. (2009). "Growth hormone and anabolic steroids:athletes are the tip of the iceberg=2009". Drug Testing and Analysis. 1 (9–10): 419–425. doi:10.1002/dta.87. PMID 20355224.